Anchor Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-232
| Closed | -$2.24K | – | 1000 |
|
|
2020
Q4 | $2.24K | Buy |
+232
| New | +$2.24K | ﹤0.01% | 836 |
|
|
2019
Q2 | – | Sell |
-1,750
| Closed | -$27.4K | – | 824 |
|
|
2019
Q1 | $27.4K | Sell |
1,750
-800
| -31% | -$12.5K | 0.01% | 524 |
|
|
2018
Q4 | $39.3K | Sell |
2,550
-50
| -2% | -$771 | 0.01% | 468 |
|
|
2018
Q3 | $56K | Sell |
2,600
-400
| -13% | -$8.62K | 0.01% | 462 |
|
|
2018
Q2 | $73K | Hold |
3,000
| – | – | 0.02% | 433 |
|
|
2018
Q1 | $51.3K | Sell |
3,000
-3,069
| -51% | -$52.4K | 0.01% | 471 |
|
|
2017
Q4 | $115K | Sell |
6,069
-13,730
| -69% | -$260K | 0.03% | 355 |
|
|
2017
Q3 | $348K | Sell |
19,799
-5,600
| -22% | -$98.6K | 0.1% | 206 |
|
|
2017
Q2 | $844K | Buy |
25,399
+500
| +2% | +$16.6K | 0.28% | 91 |
|
|
2017
Q1 | $799K | Sell |
24,899
-1,350
| -5% | -$43.3K | 0.27% | 92 |
|
|
2016
Q4 | $952K | Sell |
26,249
-2,370
| -8% | -$85.9K | 0.36% | 77 |
|
|
2016
Q3 | $1.32M | Sell |
28,619
-1,655
| -5% | -$76.1K | 0.51% | 56 |
|
|
2016
Q2 | $1.52M | Sell |
30,274
-200
| -0.7% | -$10K | 0.6% | 47 |
|
|
2016
Q1 | $1.63M | Buy |
+30,474
| New | +$1.63M | 0.67% | 41 |
|